R&D Multilateral benefit sharing mechanism for digital sequence ... Since December 2022, and COP decision 15/9, members of the Convention on Biolog
R&D Sponsored Completing a successful tech transfer Tech transfers can be difficult and every one is unique, but the right tips can help. Lannett CDMO's Grant Brock and Frantz Maignan weigh in.
News Roche's oral MS hope fenebrutinib hits the mark in phase 3 Roche's oral BTK inhibitor fenebrutinib is on track for filings next year for multiple sclerosis after clearing two phase 3 trials.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.